关于新型冠状病毒命名的思考与建议

doi:10.3969/j.issn.1673-8578.2020.02.002

中国科技术语 ›› 2020, Vol. 22 ›› Issue (2): 5-10.doi: 10.3969/j.issn.1673-8578.2020.02.002

• 新型冠状病毒与相关疾病命名专栏 • 上一篇下一篇

关于新型冠状病毒命名的思考与建议

张冬梅¹, 姜世勃²^,^*(), 石正丽³, 谭文杰⁴, 卢洪洲⁵, 曹彬⁶, 张文宏⁷, 刘叔文⁸, 钟劲⁹, 肖庚富³, 谢幼华², 邓凯¹⁰, 赵金存¹¹, 杨子峰¹¹, 宋敬东⁴, 陆路², 黄竞荷², 应天雷², 王乔², 施莽¹², 徐建青⁵, 安静¹³, 鲁凤民¹⁴, 高福⁴, 舒跃龙¹⁵, 郭德银¹²^,^*()

^1. 广东药科大学医药商学院,广东广州 510006
^2. 复旦大学上海医学院,上海 200032
^3. 中国科学院武汉病毒所,湖北武汉 430071
^4. 中国疾病预防控制中心,北京 102206
^5. 复旦大学附属公共卫生临床中心,上海 201058
^6. 中日友好医院呼吸与危重症医学科/中国医学科学院呼吸病学研究院/国家呼吸疾病临床研究中心,北京 100029
^7. 复旦大学附属华山医院,上海 200040
^8. 南方医科大学药学院,广东广州 510515
^9. 中国科学院上海巴斯德研究所,上海 200031
10.中山大学中山医学院,广东广州 510080
11.广州医科大学附属第一医院/广州健康呼吸研究院/呼吸疾病国家重点实验室,广东广州 510120
12.中山大学医学院(深圳),广东深圳 510006
13.首都医科大学基础医学院,北京 100069
14.北京大学基础医学院,北京 100191
15.中山大学公共卫生学院(深圳),广东深圳 510006

收稿日期:2020-03-23 出版日期:2020-04-25 发布日期:2020-04-27
通讯作者: 姜世勃,郭德银 E-mail:shibojiang@fudan.edu.cn;guodeyin@mail.sysu.edu.cn
作者简介:第一作者:张冬梅(1970—),女,广东药科大学教授,主要研究医药产业技术竞争情报、技术预测。通信方式:dongmei.zh@126.com。

Consideration and Suggestion for Naming the Novel Coronavirus

ZHANG Dongmei¹, JIANG Shibo²^,^*(), SHI Zhengli³, TAN Wenjie⁴, LU Hongzhou⁵, CAO Bin⁶, ZHANG Wenhong⁷, LIU Shuwen⁸, ZHONG Jin⁹, XIAO Gengfu³, XIE Youhua², DENG Kai¹⁰, ZHAO Jincun¹¹, YANG Zifeng¹¹, SONG Jingdong⁴, LU Lu², HUANG Jinghe², YING Tianlei², WANG Qiao², SHI Mang¹², XU Jianqing⁵, AN Jing¹³, LU Fengmin¹⁴, GAO Fu⁴, SHU Yuelong¹⁵, GUO Deyin¹²^,^*()

Received:2020-03-23 Online:2020-04-25 Published:2020-04-27
Contact: JIANG Shibo,GUO Deyin E-mail:shibojiang@fudan.edu.cn;guodeyin@mail.sysu.edu.cn

摘要/Abstract

摘要：

2019年12月,一种由新型冠状病毒(2019-nCoV)引起的病毒性肺炎开始在武汉暴发流行。2020年2月11日,世界卫生组织(WHO)将新型冠状病毒肺炎命名为COVID-19(冠状病毒病2019),国际病毒分类学委员会(ICTV)的冠状病毒研究小组(CSG)建议把新型冠状病毒命名为SARS-CoV-2(严重急性呼吸综合征冠状病毒2),既没有与疾病名称一致,也没有完全真实地显示该病毒本身的特征,因而立即引发关注和争议。基于COVID-19的病原学、流行病学和临床特征的基本信息,建议将新型冠状病毒命名为“人类冠状病毒2019”(human coronavirus 2019,简称HCoV-19)。文章回顾并评价了CSG的命名方法,指出他们使用基于基因序列信息进行病毒命名的方法并不合适,建议采用传统的联系疾病的病毒命名方法对具有明显疾病特点的病毒如2019-nCoV进行命名。

关键词: 冠状病毒, 肺炎, 2019新型冠状病毒, 人类冠状病毒2019, 冠状病毒病2019

Abstract:

A new type of viral pneumonia caused by a novel coronavirus emerged in Wuhan, China in December,2019. On February 11, 2020, WHO named the novel coronavirus disease as COVID-19 (coronavirus disease 2019). On the same day, the novel coronavirus was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses. The new name of the virus is not consistent with its disease name and does not completely and truthfully reflect the features of the virus itself, which immediately caused wide concerns and confusion. Based on etiological, epidemiological and clinical data of COVID-19, we propose to name the virus as human coronavirus 2019 (HCoV-19) . The CSG adopted a genome sequence-based method to name 2019-nCoV, which we think is not appropriate for this virus that has caused a distinct disease from SARS caused by SARS-CoV. We suggest that the disease-based method should be employed to name the newly identified human virus that causes a distinct disease.

Key words: coronavirus, pneumonia, 2019-nCoV, HCoV-19, COVID-19

中图分类号:

张冬梅, 姜世勃, 石正丽, 谭文杰, 卢洪洲, 曹彬, 张文宏, 刘叔文, 钟劲, 肖庚富, 谢幼华, 邓凯, 赵金存, 杨子峰, 宋敬东, 陆路, 黄竞荷, 应天雷, 王乔, 施莽, 徐建青, 安静, 鲁凤民, 高福, 舒跃龙, 郭德银. 关于新型冠状病毒命名的思考与建议[J]. 中国科技术语, 2020, 22(2): 5-10.

ZHANG Dongmei, JIANG Shibo, SHI Zhengli, TAN Wenjie, LU Hongzhou, CAO Bin, ZHANG Wenhong, LIU Shuwen, ZHONG Jin, XIAO Gengfu, XIE Youhua, DENG Kai, ZHAO Jincun, YANG Zifeng, SONG Jingdong, LU Lu, HUANG Jinghe, YING Tianlei, WANG Qiao, SHI Mang, XU Jianqing, AN Jing, LU Fengmin, GAO Fu, SHU Yuelong, GUO Deyin. Consideration and Suggestion for Naming the Novel Coronavirus[J]. China Terminology, 2020, 22(2): 5-10.

参考文献 30

[1]	Zhu N, Zhang D, Wang W , et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020,382:727-733. doi: 10.1056/NEJMoa2001017 URL pmid: 31978945
[2]	Zhou P, Yang X L, Wang X G , et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020,579:270-273. doi: 10.1038/s41586-020-2012-7 URL pmid: 32015507
[3]	Wu F, Zhao S, Yu B , et al. A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020,579:265-269. doi: 10.1038/s41586-020-2008-3 URL pmid: 32015508
[4]	Gorbalenya A E, Baker S C, Baric R S , et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2[J/OL]. Nat Microbiol, 2020-03-02, https://doi.org/10.1038/s41564-020-0695-z.
[5]	Enserink M . Update: ‘A bit chaotic.’ Christening of new coronavirus and its disease name create confusion[J/OL]. Science, 2020-02-12, https://doi:10.1126/science.abb2806.
[6]	World Health Organization. Coronavirus disease (COVID-19) outbreak [EB/OL].(2020- 03-11)[2020-03-13]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
[7]	Nature news. Chinese virologists raise concerns about virus name[J/OL]. Nature, 2020-02-13, https://www.nature.com/articles/d41586-020-00154-w.
[8]	Jiang S, Shi Z, Shu Y , et al. A distinct name is needed for the new coronavirus[J]. Lancet, 2020,395(10228):949. doi: 10.1016/S0140-6736(20)30419-0 URL pmid: 32087125
[9]	Jiang S . Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees[J]. Nature, 2020,579:321. doi: 10.1038/d41586-020-00751-9 URL pmid: 32179860
[10]	Gates B . Responding to Covid-19—A Once-in-a-Centu-ry Pandemic? [J]. N Engl J Med, 2020-02-28,DOI: 10.1056/NEJMp2003762.
[11]	Xia S, Yan L, Xu W , et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike[J]. Sci Adv, 2019, 5(4):eaav4580.
[12]	Jiang S, Du L, Shi Z . An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies[J]. Emerg Microb Infect, 2020,9:275-277. doi: 10.1080/22221751.2020.1723441 URL pmid: 32005086
[13]	Jiang S, Shi Z . The first disease X is caused by a highly transmissible acute respiratory syndrome coronavirus[J/OL]. Virol Sin, 2020- 02- 14 , .
[14]	Xia S, Liu M, Wang C , et al. Inhibiting SARS-CoV-2 infection by a highly potent pan-coronavirus fusion inhibitor targeting S protein with high capacity to mediate membrane fusion[J/OL]. Cell Res, accepted. bioRxiv, 2020- 03- 12 , http://doi.org/10.1101/2020.03.09.983247.
[15]	Xia S, Zhu Y, Liu M , et al. Fusion mechanism of2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein[J/OL]. Cell Mol Immunol, 2020-02-11, https://doi.org/10.1038/s41423-020-0374-2.
[16]	Wang M, Cao R, Zhang L , et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 2020,30:269-271. doi: 10.1038/s41422-020-0282-0 URL pmid: 32020029
[17]	Gautret P, Lagier J-C, Parola V P , et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial[J/OL]. Int J Antimicrob Agents,2020-03-20, https://doi.org/10.1016/j.ijantimicag.2020.105949.
[18]	de Wit E, van Doremalen N, Falzarano D , et al. SARS and MERS: recent insights into emerging coronaviruses[J]. Nat Rev Microbiol, 2016,14:523-534. doi: 10.1038/nrmicro.2016.81 URL pmid: 27344959
[19]	Guan W, Ni Z, Hu Y , et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med, 2020-02-28, DOI: 10.1056/NEJMoa2002032.
[20]	Rothe C, Schunk M, Sothmann P , et al. Transmission of2019-nCoV Infection from an Asymptomatic Contact in Germany[J]. N Engl J Med, 2020-03-05,DOI: 10.1056/NEJMc2001468.
[21]	Chan J F, Yuan S, Kok K H , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster[J]. Lancet, 2020,395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9 URL pmid: 31986261
[22]	Li Q, Guan X, Wu P , et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia[J]. N Engl J Med, 2020-01-29 ,DOI: 10.1056/NEJMoa2001316. doi: 10.1056/NEJMoa2001316 URL pmid: 31995857
[23]	Huang C, Wang Y, Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5 URL pmid: 31986264
[24]	Wang C, Horby P W, Hayden F G , et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020,395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9 URL pmid: 31986257
[25]	Wang D, Hu B, Hu C , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J/OL]. JAMA, 2020-02-07, https://doi:10.1001/jama.2020. 1585.
[26]	Fauci A S, Lane H C, Redfield R R . Covid-19 — Navigating the Uncharted[J]. N Engl J Med, 2020-02-28,DOI: 10.1056/NEJMe2002387.
[27]	Kupferschmidt K, Cohen J . Can China’s COVID-19 strategy work elsewhere?[J]. Science, 2020,367:1061-1062. doi: 10.1126/science.367.6482.1061 URL pmid: 32139521
[28]	Alltucker K, O’Donnell J . When will the threat of coronavirus end? It might return every winter[N/OL]. (2020-02-06)[2020-03-11]. USA Today, https://www.usatoday.com/story/news/health/2020/02/06/coronavirus-wuhan-china-recurring-winter-illness-flu/4665482002.
[29]	Jiang S, Xia S, Ying T , et al. A novel coronavirus (2019-nCoV) causing pneumonia associated respiratory syndrome[J/OL]. Cell Mol Immunol, 2020-02-05, https://doi.org/10.1038/s41423-020-0372-4.
[30]	World Health Organization. WHO issues best practices for naming new human infectious diseases [EB/OL]. ( 2015- 05-08)[2020-03-13]. https://www.who.int/mediacentre/news/notes/2015/naming-new-diseases/en.

关于新型冠状病毒命名的思考与建议

Consideration and Suggestion for Naming the Novel Coronavirus

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 10

编辑推荐

Metrics

本文评价

[1]	李龙兴, 王宪. 应急语言服务视角下的新冠肺炎医学英语专题术语表开发[J]. 中国科技术语, 2021, 23(2): 32-41.
[2]	蒋向勇, 邵娟萍. 认知术语学主要理论与术语生成——以新冠肺炎命名为例[J]. 中国科技术语, 2020, 22(5): 15-23.
[3]	施麟麒, 桂双. 传染病命名问题纵谈[J]. 中国科技术语, 2020, 22(5): 24-32.
[4]	曾江霞. 多模态大数据语境下科技术语翻译标准分析——以新冠肺炎和新冠病毒术语翻译为例[J]. 中国科技术语, 2020, 22(5): 33-41.
[5]	缪蓬. 从“非典”和“新冠”看疾病新名词的定名策略[J]. 中国科技术语, 2020, 22(5): 42-45.
[6]	冯志伟. 我对于“新冠肺炎”译名的建议[J]. 中国科技术语, 2020, 22(2): 11-13.
[7]	殷健. 基于过程性特征的术语命名、翻译与传播的文化安全思考——以新冠肺炎相关术语为例[J]. 中国科技术语, 2020, 22(2): 14-20.
[8]	王佩, 车云峰. 新冠肺炎疫情医用个人防护用品英译探微[J]. 中国科技术语, 2020, 22(2): 46-49.
[9]	王乐. 简介“中东呼吸综合征”[J]. 中国科技术语, 2015, 17(4): 62-64.
[10]	余文海. 浅谈医学术语pneumonia与pneumonitis[J]. 中国科技术语, 2009, 11(2): 51-52.